The San Diego biotechnology company Nanogen said yesterday that it has filed for bankruptcy protection with plans to sell off nearly all its assets to the French company Elitech Group. The Chapter 11 ...

ELITech is an in-vitro diagnostic company Hospitals and laboratories in more than 100 countries use ELITech’s products PAI invested in the business in 2017 UPDATED. PAI Partners will hit a 3.7x gross ...

SAN DIEGO (May 14, 2008) - Nanogen, Inc, developer of molecular and rapid diagnostic products, today announced that it has executed an asset purchase agreement with The Elitech Group ("Elitech"), a ...

DENVER and PARIS, July 19 Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and the ELITech Group, a Paris, France-based, privately ...

Upon completion of the transaction, ELITech is expected to operate as a stand-alone entity within Bruker’s Microbiology and Infection Diagnostics division. Bruker plans to fund the acquisition with ...

Bruker Corporation BRKR recently entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of the pre-eminent private equity firm PAI Partners, to acquire ...

The once high-flying diagnostic company Nanogen has filed for Chapter 11 bankruptcy protection, saying that it plans to sell off almost all its assets to French company Elitech Group for $25.7 million ...